AACT Polyclonal Antibody, Cy5 Conjugated
Product Specifications
Background
Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2.
Synonyms
ACT; AACT; GIG24; GIG25; Alpha-1-antichymotrypsin; Cell growth-inhibiting gene 24/25 protein; Serpin A3; SERPINA3
Gene ID
12
Swiss Prot
P01011
Cellular Locus
Secreted
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
121-320/423
Target
AACT
Clonality
Polyclonal
Conjugation
Cy5
Source
KLH conjugated synthetic peptide derived from human AACT-Alpha1
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
625,650nm/670nm
Concentration
1ug/ul
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
12
Isotype
IgG
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
128185 50 µg
ICA1L (Islet Cell Autoantigen 1-like Protein, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 14 Protein, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 15 Protein, ALS2CR14, ALS2CR15, DKFZp434E1919, MGC138440)
Sign In for Pricing
View Details 
MBS6314611-01 0.2 mL
KRT24, CT (Keratin, type I cytoskeletal 24,KRT24,KA24) (PE)
Sign In for Pricing
View Details